Patents by Inventor Kazuki SAWAMOTO

Kazuki SAWAMOTO has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • TREATMENT OF MUCOPOLYSACCHARIDOSIS IVA
    Publication number: 20210292789
    Abstract: Provided herein are gene therapy methods for the treatment of mucopolysaccharidosis type IVA (MPS IVA) involving the use of recombinant adeno-associated viruses (rAAVs) to deliver human N-acetylgalactosamine-6-sulfate sulfatase (hGALNS) to the bone of a human subject diagnosed with MPS IVA. Also provided herein are rAAVs that can be used in the gene therapy methods and methods of making such rAAVs.
    Type: Application
    Filed: July 26, 2019
    Publication date: September 23, 2021
    Inventors: Shunji Tomatsu, Kazuki Sawamoto, Subha Karumuthil-Melethil, Olivier Danos
  • AN AGENT, A DEVICE AND A BLOOD-CIRCULATION SYSTEM FOR TREATING LYSOSOMAL STORAGE DISEASES, AND A METHOD FOR TREATING LYSOSOMAL STORAGE DISEASES
    Publication number: 20200206323
    Abstract: A therapeutic agent containing, as an effective component, a glycolytic enzyme which is different from a deficient protein of a patient with lysosomal storage disease as a subject and/or a glycolytic enzyme which does not have a mannose 6-phosphate moiety or a mannose moiety.
    Type: Application
    Filed: September 7, 2018
    Publication date: July 2, 2020
    Applicants: THE NEMOURS FOUNDATION, SEIKAGAKU CORPORATION
    Inventors: Shunji TOMATSU, Kazuki SAWAMOTO, Takehiko NAKAMURA, Ikue KITAZAWA, Hideyuki FUTATSUMORI